Read the following scenario and answer all questions in red and then post answers.
Please be on time… Must have good feedback rating
Imagine that a pharmaceutical company is testing a new medication to treat major depression in people whose symptoms have not been helped by existing medications.You are part of a panel of professionals who must decide if the drug should be considered safe for human trials. The null hypothesis is that the drug is considered to be safe. The alternative hypothesis is that the drug is considered to be unsafe. In the above scenario, would a Type I or Type II error be worse? Why? Be sure to spell out what a Type I and Type II error would be in this example so your explanation is clear.
Should the drug be considered safe for human trials?
Address the following as you prepare for your posting:
- Consider an example of when it is acceptable to have a p of .05 versus .01. What effect would this have on your interpretation of the drug’s safety?
- Consider the likelihood of making a Type I or Type II error. What effect could these errors have on your interpretation of the drug’s safety?
- Draft a recommendation regarding whether the drug should be seen as safe for human trials.
- Consider how the scenario would need to change in order to have a different recommendation.
Post by Day 3 your recommendation on whether human testing trials should begin on the drug described in the scenario. Explain why or why not. Specifically, include how the use of different p values (.05 versus .01) and concerns related to Type I and II errors would influence your recommendation. What conditions would need to change for your recommendation to change? Justify your post using the Learning Resources and current literature.
Respond by Day 6 to at least one of your peers by supporting or challenging key points of their recommendation. Justify your response using the Learning Resources.
0 comments